By Mark Melchionna
June 29, 2023 – Amid the ongoing concerns surrounding virtual prescribing allowances for attention-deficit hyperactivity disorder (ADHD) medications, a new study found that health systems provide prescriptions for this condition and anxiety at…
Continue Reading
The U.S. Drug Enforcement Administration’s stance on prescribing via telehealth has been evolving, with hints toward an appetite for lasting flexibilities. This, among other policy shifts, has a direct impact on healthcare provider organizations…
Continue Reading
What You Should Know:Today, the Drug Enforcement Administration (DEA) and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued the “Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications” – a…
Continue Reading
Top News
The Drug Enforcement Administration, reacting to the record 38,000 comments it received about its intention to reinstate pre-COVID telehealth prescribing limitations for controlled drugs with the end of the public health emergency, will…
Continue Reading
After the Drug Enforcement Administration (DEA) announced Wednesday that it is temporarily extending Covid-19 flexibilities for the prescribing of controlled substances via telemedicine, several telehealth advocates came out in support of the decision.
These flexibilities…
The unprecedented expansion of telehealth and mental health care during the pandemic was a monumental shift for behavioral health care in more ways than one.
The flexibilities for behavioral health visits that resulted from the…
